Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 133,010 | 127,785 | 111,585 | 99,414 | 90,377 |
| Cost of Goods | 25,537 | 23,421 | 23,018 | 22,780 | 20,806 |
| Gross Profit | 107,473 | 104,364 | 88,567 | 76,634 | 69,571 |
| Operating Expenses | 105,407 | 109,774 | 103,768 | 101,636 | 83,061 |
| Operating Income | 2,603 | -4,989 | -15,183 | -24,222 | -12,684 |
| Interest Expense | 3,606 | 3,589 | 3,596 | 3,579 | 3,586 |
| Other Income | 3,646 | 3,119 | 5,131 | 3,435 | 2,382 |
| Pre-tax Income | 2,643 | -5,459 | -13,648 | -24,366 | -13,888 |
| Income Tax | -262 | 402 | 1,029 | -576 | 347 |
| Net Income Continuous | 2,905 | -5,861 | -14,677 | -23,790 | -14,235 |
| Net Income | $2,905 | $-5,861 | $-14,677 | $-23,790 | $-14,235 |
| EPS Basic Total Ops | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 |
| EPS Basic Continuous Ops | 0.06 | -0.12 | -0.30 | -0.49 | -0.30 |
| EPS Diluted Total Ops | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 |
| EPS Diluted Continuous Ops | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 |
| EPS Diluted Before Non-Recurring Items | 0.05 | -0.12 | -0.30 | -0.49 | -0.30 |
| EBITDA(a) | $9,108 | $1,494 | $-8,698 | $-17,750 | $-6,205 |